Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer.
about
Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancerRestoration of mitochondria function as a target for cancer therapyMetformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer.HK2 is a radiation resistant and independent negative prognostic factor for patients with locally advanced cervical squamous cell carcinomaPrognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cellsPKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma.A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line modelsChrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2.Kaempferol inhibits cell proliferation and glycolysis in esophagus squamous cell carcinoma via targeting EGFR signaling pathway.Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cells.Expression patterns of three regulation enzymes in glycolysis in esophageal squamous cell carcinoma: association with survival.Chaperone-mediated autophagy substrate proteins in cancer.Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development.Proteomic and Bioinformatic Studies for the Characterization of Response to Pemetrexed in Platinum Drug Resistant Ovarian Cancer.Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment.Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism.Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer
P2860
Q26746203-60FD9D75-C51C-4F6C-BF9B-56E5FD7143F9Q26864167-60A63899-8635-4989-972C-6726A2E7F544Q33890763-77B6D689-D111-4736-95AE-71DA5C93B257Q35741135-CA02A15E-9CAA-4D75-8AB8-E786BD4FC75AQ36185753-0AC657C0-B387-41CC-97B6-4A699E48D396Q36255034-48CCC54A-0D1D-4B89-8BCB-F92EF58F3DEFQ36292690-82B4E75A-062B-48F7-BDD0-75F0EC3A0F1AQ36413261-6C402431-A2AF-4C14-A416-B530D5262A83Q37713441-A8174C2C-680A-452A-8747-765CB44EB65DQ38797639-6595CF9E-3545-4391-84E2-9E2A976FB4A9Q38948714-4192DD93-9724-467B-85AE-3811780A375CQ38971389-AE1D81BF-CCD7-4B6A-8C66-0EF4B560D193Q41613132-8E7B441F-4825-4D3D-A401-E29B2F92280BQ50105551-5BA2725F-FF79-474C-B8E2-BC9456B7A1F8Q55311424-196D814E-899A-4322-ACA0-5A4D7AD64282Q55396364-3AA31D8D-9C28-4A4A-B426-DFB413BB4F66Q55396904-124545C0-018E-43DB-9104-CB3B11B0A687Q58723357-3E100AD4-0025-477F-AE12-CB718A3EC607
P2860
Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Association of overexpression ...... in epithelial ovarian cancer.
@en
Association of overexpression ...... in epithelial ovarian cancer.
@nl
type
label
Association of overexpression ...... in epithelial ovarian cancer.
@en
Association of overexpression ...... in epithelial ovarian cancer.
@nl
prefLabel
Association of overexpression ...... in epithelial ovarian cancer.
@en
Association of overexpression ...... in epithelial ovarian cancer.
@nl
P2093
P2860
P1476
Association of overexpression ...... in epithelial ovarian cancer.
@en
P2093
Haeryoung Kim
Hee Seung Kim
Hyun Hoon Chung
Mi-Kyung Kim
Yong Sang Song
Yong-Beom Kim
P2860
P2888
P304
P356
10.1007/S10238-013-0250-9
P577
2013-08-15T00:00:00Z